0000899243-20-018356.txt : 20200702
0000899243-20-018356.hdr.sgml : 20200702
20200702191501
ACCESSION NUMBER: 0000899243-20-018356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waynick Denelle J
CENTRAL INDEX KEY: 0001816440
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 201011569
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER NAME:
FORMER CONFORMED NAME: Waynick Denelle
DATE OF NAME CHANGE: 20200629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia, Inc.
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: MyoKardia Inc
DATE OF NAME CHANGE: 20120618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-01
0
0001552451
MyoKardia, Inc.
MYOK
0001816440
Waynick Denelle J
C/O MYOKARDIA, INC.
1000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
0
1
0
0
General Counsel
Stock Option (Right to Buy)
93.84
2020-07-01
4
A
0
80000
0.00
A
2030-06-30
Common Stock
80000
80000
D
Restricted Stock Units
2020-07-01
4
A
0
25000
0.00
A
Common Stock
25000
25000
D
25% of the shares subject to this option shall vest and become exercisable on June 29, 2021, and the remainder shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. In addition, in the event the Reporting Person's service relationship is terminated by the Issuer or any successor without Cause (as defined in the Issuer's stock plan) or for Good Reason (as defined in the Issuer's Change in Control and Severance Policy) within one year following the consummation of a Sale Event (as defined in the Issuer's stock plan), any unvested shares underlying the option will become fully vested as of the date of such termination in accordance with the Issuer's Change in Control and Severance Policy.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs shall vest in four annual installments after July 1, 2020, subject to the Reporting Person's continued service with the Issuer on each such vesting date. In addition, in the event the Reporting Person's service relationship is terminated by the Issuer or any successor without Cause (as defined in the Issuer's stock plan) or for Good Reason (as defined in the Issuer's Change in Control and Severance Policy) within one year following the consummation of a Sale Event (as defined in the Issuer's stock plan), any unvested units will become fully vested as of the date of such termination in accordance with the Issuer's Change in Control and Severance Policy.
/s/ Denelle J. Waynick
2020-07-02